Anat Yerushalmy-Feler1,2, Sharona Kern-Isaacs2, Shlomi Cohen3,4. 1. Pediatric Gastroenterology Unit, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, 6 Weizman Street, 6423906, Tel Aviv, Israel. 2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 3. Pediatric Gastroenterology Unit, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, 6 Weizman Street, 6423906, Tel Aviv, Israel. shlomico@tlvmc.gov.il. 4. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. shlomico@tlvmc.gov.il.
Abstract
PURPOSE OF REVIEW: Patients with inflammatory bowel disease (IBD) are predisposed to infections. Cytomegalovirus (CMV) colitis in adult IBD patients, particularly ulcerative colitis (UC), is related to severe or steroid-refractory disease. The aim of this review is to summarize the data on the prevalence and role of CMV colitis in children with IBD. RECENT FINDINGS: Data on CMV colitis in children continue to be very limited due to its rarity. As in adults, children with coexisting UC and CMV tend to have more severe colitis, are resistant to corticosteroids, and are at high risk for colectomies on short- and long-term follow-up. In children, as in adults, the significance of CMV colitis, in terms of whether CMV is a pathogen that aggravates acute severe colitis or simply reflects disease severity, is still unknown.
PURPOSE OF REVIEW: Patients with inflammatory bowel disease (IBD) are predisposed to infections. Cytomegalovirus (CMV) colitis in adult IBD patients, particularly ulcerative colitis (UC), is related to severe or steroid-refractory disease. The aim of this review is to summarize the data on the prevalence and role of CMV colitis in children with IBD. RECENT FINDINGS: Data on CMV colitis in children continue to be very limited due to its rarity. As in adults, children with coexisting UC and CMV tend to have more severe colitis, are resistant to corticosteroids, and are at high risk for colectomies on short- and long-term follow-up. In children, as in adults, the significance of CMV colitis, in terms of whether CMV is a pathogen that aggravates acute severe colitis or simply reflects disease severity, is still unknown.
Authors: J N Udall; J M Hempe; E Schmidt-Sommerfeld; W D Scheer; E Mannick; U Blecker; H Correa Journal: J Pediatr Gastroenterol Nutr Date: 1999-05 Impact factor: 2.839
Authors: B Ghidini; M Bellaiche; D Berrebi; J Viala; J P Hugot; J F Mougenot; A Munck; M Peuchmaur; J P Cezard Journal: Gut Date: 2006-04 Impact factor: 23.059
Authors: Uri Kopylov; Konstantinos Papamichael; Konstantinos Katsanos; Matti Waterman; Ariella Bar-Gil Shitrit; Trine Boysen; Francisco Portela; Armando Peixoto; Andrew Szilagyi; Marco Silva; Giovanni Maconi; Ofir Har-Noy; Peter Bossuyt; Gerassimos Mantzaris; Manuel Barreiro de Acosta; Maria Chaparro; Dimitrios K Christodoulou; Rami Eliakim; Jean-Francois Rahier; Fernando Magro; David Drobne; Marc Ferrante; Elena Sonnenberg; Britte Siegmund; Vinciane Muls; Tamara Thurm; Henit Yanai; Iris Dotan; Tim Raine; Avi Levin; Eran Israeli; Fahd Ghalim; Franck Carbonnel; Severine Vermeire; Shomron Ben-Horin; Xavier Roblin Journal: Inflamm Bowel Dis Date: 2017-09 Impact factor: 5.325
Authors: Laurie B Grossberg; Ghideon Ezaz; Douglas Grunwald; Jonah Cohen; Kenneth R Falchuk; Joseph D Feuerstein Journal: J Clin Gastroenterol Date: 2018-03 Impact factor: 3.062
Authors: Annika Gauss; Simon Rosenstiel; Paul Schnitzler; Ulf Hinz; Tobias Rehlen; Martina Kadmon; Robert Ehehalt; Wolfgang Stremmel; Anna Zawierucha Journal: Eur J Gastroenterol Hepatol Date: 2015-06 Impact factor: 2.566
Authors: Jeffrey D McCurdy; Andrea Jones; Felicity T Enders; Jill M Killian; Edward V Loftus; Thomas C Smyrk; David H Bruining Journal: Clin Gastroenterol Hepatol Date: 2014-06-30 Impact factor: 11.382